Page 46 - Drug Discovery and Development: Prospects and Challenges

36 / Drug Discovery and Development: Prospects and Challenges

Figure 26: Hydrogel samples with different concentrations after undergoing five consecutive cycles;

(A) control (without sample), (B) 0.25% of C. asiatica sample fraction, (C) 0.5% of C. asiatica

Figure 26: Hydrogel samples with different concentrations after undergoing

sample fraction, and (D) 1.0% of C. asiatica sample fraction
five consecutive cycles; (A) control (without sample), (B) 0.25% of
Figure 26: Hydrogel samples with different concentrations after undergoing five consecutive cycles;
C. asiatica sample fraction, (C) 0.5% of C. asiatica sample fraction,
(A) control (without sample), (B) 0.25% of C. asiatica sample fraction, (C) 0.5% of C. asiatica
and (D) 1.0% of C. asiatica sample fraction
sample fraction, and (D) 1.0% of C. asiatica sample fraction
Pre-Commercialisation of Pegaga Serum

Pre-Commercialisation of Pegaga Serum
Regarding its health benefit, especially, for healthy skin, the research on pegaga has extended
Pre-Commercialisation of Pegaga Serum
Regarding its health benefit, especially, for healthy skin, the research on pegaga has extended
Regarding its health benefit, especially, for healthy skin, the research
for the development of pegaga-based cosmetic products. The effectiveness of C.
for the development of pegaga-based cosmetic products. The effectiveness of C. asiatica has been asiatica has been
on pegaga has extended for the development of pegaga-based cosmetic
formulated as a serum preparation, namely Serum X (Figure 27), which was sponsored by Malaysia
products. The effectiveness of C. asiatica has been formulated as a
formulated as a serum preparation, namely Serum X (Figure 27), which was sponsored by Malaysia
Technology Development Cooperation (MTDC) under the commercialisation of R&D Fund (CRDF)
serum preparation, namely Serum X (Figure 27), which was sponsored
Technology Development Cooperation (MTDC) under the commercialisation of R&D Fund (CRDF)
grant scheme with financial aid totalling RM 69,000 for marketing purposes. The product is currently
by Malaysia Technology Development Cooperation (MTDC) under the
under market validation by one of the cosmetic companies for further development.
commercialisation of R&D Fund (CRDF) grant scheme with financial
grant scheme with financial aid totalling RM 69,000 for marketing purposes. The product is currently

aid totalling RM 69,000 for marketing purposes. The product is currently
under market validation by one of the cosmetic companies for further development.
under market validation by one of the cosmetic companies for further
development.

Figure 27: Serum X on the shelf during market validation

40

Figure 27: Serum X on the shelf during market validation
Figure 27: Serum X on the shelf during market validation

40